Oncogenic protein kinase Cι signaling mechanisms in lung cancer: Implications for improved therapeutic strategies

Ning Yin, Yi Liu, Nicole R. Murray, Alan P. Fields

Research output: Contribution to journalArticle

Abstract

Protein Kinase Cι (PKCι) is a major oncogene involved in the initiation, maintenance and progression of numerous forms of human cancer. In the lung, PKCι is necessary for the maintenance of the transformed phenotype of the two major forms of non-small cell lung cancer (NSCLC), lung adenocarcinoma (LADC) and lung squamous cell carcinoma (LSCC). In addition, PKCι is necessary for both LADC and LSCC tumorigenesis by establishing and maintaining a highly aggressive stem-like, tumor-initiating cell phenotype. Interestingly however, while PKCι signaling in these two major lung cancer subtypes shares some common elements, it also drives distinct, sub-type specific pathways. Furthermore, recent analysis has revealed both PKCι-dependent and PKCι-independent pathways to LADC development. Herein, we discussion our current knowledge of oncogenic PKCι signaling in LADC and LSCC, and discuss these findings in the context of how they may inform strategies for improved therapeutic intervention in these deadly diseases.

Original languageEnglish (US)
Article number100656
JournalAdvances in Biological Regulation
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Protein Kinase C
Lung Neoplasms
Squamous Cell Carcinoma
Therapeutics
Maintenance
Phenotype
Neoplastic Stem Cells
Adenocarcinoma of lung
Oncogenes
Non-Small Cell Lung Carcinoma
Carcinogenesis
Lung
Neoplasms

Keywords

  • Genetically-engineered mouse models
  • Lung adenocarcinoma
  • Lung squamous cell carcinoma
  • Oncogenic signaling pathways
  • Protein kinase Cι

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

@article{7b2337d9f9dc4bc5a26b567c5676dfdd,
title = "Oncogenic protein kinase Cι signaling mechanisms in lung cancer: Implications for improved therapeutic strategies",
abstract = "Protein Kinase Cι (PKCι) is a major oncogene involved in the initiation, maintenance and progression of numerous forms of human cancer. In the lung, PKCι is necessary for the maintenance of the transformed phenotype of the two major forms of non-small cell lung cancer (NSCLC), lung adenocarcinoma (LADC) and lung squamous cell carcinoma (LSCC). In addition, PKCι is necessary for both LADC and LSCC tumorigenesis by establishing and maintaining a highly aggressive stem-like, tumor-initiating cell phenotype. Interestingly however, while PKCι signaling in these two major lung cancer subtypes shares some common elements, it also drives distinct, sub-type specific pathways. Furthermore, recent analysis has revealed both PKCι-dependent and PKCι-independent pathways to LADC development. Herein, we discussion our current knowledge of oncogenic PKCι signaling in LADC and LSCC, and discuss these findings in the context of how they may inform strategies for improved therapeutic intervention in these deadly diseases.",
keywords = "Genetically-engineered mouse models, Lung adenocarcinoma, Lung squamous cell carcinoma, Oncogenic signaling pathways, Protein kinase Cι",
author = "Ning Yin and Yi Liu and Murray, {Nicole R.} and Fields, {Alan P.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.jbior.2019.100656",
language = "English (US)",
journal = "Advances in Biological Regulation",
issn = "2212-4926",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Oncogenic protein kinase Cι signaling mechanisms in lung cancer

T2 - Implications for improved therapeutic strategies

AU - Yin, Ning

AU - Liu, Yi

AU - Murray, Nicole R.

AU - Fields, Alan P.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Protein Kinase Cι (PKCι) is a major oncogene involved in the initiation, maintenance and progression of numerous forms of human cancer. In the lung, PKCι is necessary for the maintenance of the transformed phenotype of the two major forms of non-small cell lung cancer (NSCLC), lung adenocarcinoma (LADC) and lung squamous cell carcinoma (LSCC). In addition, PKCι is necessary for both LADC and LSCC tumorigenesis by establishing and maintaining a highly aggressive stem-like, tumor-initiating cell phenotype. Interestingly however, while PKCι signaling in these two major lung cancer subtypes shares some common elements, it also drives distinct, sub-type specific pathways. Furthermore, recent analysis has revealed both PKCι-dependent and PKCι-independent pathways to LADC development. Herein, we discussion our current knowledge of oncogenic PKCι signaling in LADC and LSCC, and discuss these findings in the context of how they may inform strategies for improved therapeutic intervention in these deadly diseases.

AB - Protein Kinase Cι (PKCι) is a major oncogene involved in the initiation, maintenance and progression of numerous forms of human cancer. In the lung, PKCι is necessary for the maintenance of the transformed phenotype of the two major forms of non-small cell lung cancer (NSCLC), lung adenocarcinoma (LADC) and lung squamous cell carcinoma (LSCC). In addition, PKCι is necessary for both LADC and LSCC tumorigenesis by establishing and maintaining a highly aggressive stem-like, tumor-initiating cell phenotype. Interestingly however, while PKCι signaling in these two major lung cancer subtypes shares some common elements, it also drives distinct, sub-type specific pathways. Furthermore, recent analysis has revealed both PKCι-dependent and PKCι-independent pathways to LADC development. Herein, we discussion our current knowledge of oncogenic PKCι signaling in LADC and LSCC, and discuss these findings in the context of how they may inform strategies for improved therapeutic intervention in these deadly diseases.

KW - Genetically-engineered mouse models

KW - Lung adenocarcinoma

KW - Lung squamous cell carcinoma

KW - Oncogenic signaling pathways

KW - Protein kinase Cι

UR - http://www.scopus.com/inward/record.url?scp=85073557108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073557108&partnerID=8YFLogxK

U2 - 10.1016/j.jbior.2019.100656

DO - 10.1016/j.jbior.2019.100656

M3 - Article

C2 - 31623973

AN - SCOPUS:85073557108

JO - Advances in Biological Regulation

JF - Advances in Biological Regulation

SN - 2212-4926

M1 - 100656

ER -